Effect of Vojta Therapy on Covid-19 Respiratory Disease

Not Applicable

• Conditions: COVID-19 Acute Respiratory Distress Syndrome

• Registration Number: NCT05031858
• Lead Sponsor: NUMEN Foundation

Brief Summary

Vojta therapy is a physiotherapy intervention with scientific evidence in respiratory pathologies in children and proven in adults. In this pilot study with an RCT design, its effect in adult patients with respiratory pathology caused by the SARS-CoV-2 virus will be studied. The non-invasive and non-painful technique consists of applying tolerable pressure to specific areas of the patient's body. The objective is to activate, in a reflex way, the ventilatory physiology. It is compared with the conventional respiratory physiotherapy approach.

Detailed Description

Not available

Study Timeline

• Status Verified: 2021-08
• Study First Submitted: 2021-08-28
• Study First Submitted QC: 2021-08-30
• Last Update Submitted: 2021-08-30
• Study First Posted: 2021-09-02
• Last Update Posted: 2021-09-02
• Study Start: 2021-09-25
• Primary Completion: 2021-12-20
• Study Completion: 2022-04-15

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• respiratory disease by covid-19

Exclusion Criteria

• patient older than 75 years

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Breathing frequency	3 weeks	frequency of respiratory cycles per minute
Stay time	3 weeks	Days of stay in the intermediate respiratory care unit
SpO2	3 weeks	Oxygen saturation